Is multipleSNPtesting inBRCA2andBRCA1female carriers ready for use in clinical practice? Results from a large Genetic Centre in theUK

Authors:

Abstract
BRCA1andBRCA2are major breast cancer susceptibility genes. Nineteen single nucleotide polymorphisms (SNPs) at 18 loci have been associated with breast cancer. We aimed to determine whether these predict breast cancer incidence in women withBRCA1/BRCA2mutations.BRCA1/2mutation carriers identified through the Manchester genetics centre between 1996 and 2011 were included. Using published odds ratios (OR) and risk allele frequencies, we calculated an overall breast cancer riskSNPscore (OBRS) for each woman. The relationship betweenOBRSand age at breast cancer onset was investigated using the Cox proportional hazards model, and predictive ability assessed using Harrell'sCconcordance statistic. InBRCA1mutation carriers we found no association betweenOBRSand age at breast cancer onset:ORfor the lowest risk quintile compared to the highest was 1.20 (95%CI0.82–1.75, Harrell'sC = 0.54), but inBRCA2mutation carriers the association was significant (ORfor the lowest risk quintile relative to the highest was 0.47 (95%CI0.33–0.69, Harrell'sC = 0.59). The 18 validated breast cancerSNPsdifferentiate breast cancer risks between women withBRCA2mutations, but notBRCA1. It may now be appropriate to use theseSNPsto help women withBRCA2mutations make maximally informed decisions about management options.

This publication has 21 references indexed in Scilit: